REQUEST A DEMO
Total
USD $0.00
Search more companies

Sunvet Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sunvet Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sunvet Pharma Private Limited is based in India. The head office is in Panchkula. It operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on January 18, 2002. The total number of employees is currently 21 (2025). There was a net sales revenue increase of 32.07% reported in Sunvet Pharma Private Limited’s latest financial highlights for 2025. Its’ total assets recorded a growth of 16.8%. In, 2025, the company’s net profit margin decreased by 0.03%.

Legal Address
H.No. 518, Sector-8, Urban Estate,
Panchkula; Haryana; Postal Code: 134102

Contact Details: Purchase the Sunvet Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Sunvet Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Sunvet Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Sunvet Pharma Private Limited report to view the information.
Incorporation Date:
January 18, 2002
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Sunvet Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
32.07%
Total Operating Revenue
32%
Operating Profit
19.84%
EBITDA
13.46%
Net Profit/Loss for the Period
21.68%
Total Assets
16.8%
Total Equity
2.29%
Operating Profit Margin
-0.12%
Net Profit Margin
-0.03%
Return on Equity (ROE)
0.36%
Debt / Equity
9%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?